Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2020-06-17 | 2022-02-09 | 118046 |
| APO-OXCARBAZEPINE | 600MG | TABLET | Resolved | 2022-03-25 | 2022-05-25 | 157311 |
| APO-OXCARBAZEPINE | 150MG | TABLET | Resolved | 2024-02-09 | 2024-05-10 | 219159 |
| APO-OXCARBAZEPINE | 600MG | TABLET | Resolved | 2020-06-10 | 2022-02-09 | 117395 |
| APO-OXCARBAZEPINE | 150MG | TABLET | Resolved | 2020-06-17 | 2022-02-09 | 118043 |
| APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2024-04-05 | 2024-05-10 | 224598 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187229 |
| APO-OXYBUTYNIN | 1MG | SYRUP | Actual shortage | 2017-08-13 | 2017-10-05 | 19045 |
| APO-OXYBUTYNIN | 5MG | TABLET | Actual shortage | 2025-03-07 | 2025-03-07 | 252151 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-06-16 | 2023-07-13 | 195086 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-27 | 183474 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2022-12-23 | 2023-01-26 | 179456 |
| APO-OXYBUTYNIN - TAB 5MG | 5MG | TABLET | Resolved | 2017-04-07 | 2018-11-30 | 5865 |
| APO-OXYBUTYNIN - TAB 5MG | 5MG | TABLET | Resolved | 2017-06-28 | 2018-11-30 | 14201 |
| APO-OXYBUTYNIN - TAB 5MG | 5 MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 414 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-26 | 2017-10-24 | 17260 |
| APO-OXYCODONE CR | 80.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-23 | 2023-08-12 | 196312 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-27 | 2020-03-02 | 99792 |
| APO-OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2021-12-24 | 2022-03-21 | 151889 |
| APO-OXYCODONE CR | 5.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-07-22 | 2022-09-23 | 165332 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
| APO-DIPYRIDAMOLE-FC TAB 25MG | 25MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101888 |
| APO-DIPYRIDAMOLE-FC TAB 50MG | 50MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101891 |
| APO-DIPYRIDAMOLE-FC TAB 75MG | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60443 |
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60447 |
| APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60450 |
| APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60453 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-29 | 60459 |
| APO-DOXY TABS 100MG | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4707 |
| APO-ENALAPRIL TAB 10MG | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-12-05 | 60462 |
| APO-ENALAPRIL TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-19 | 60465 |
| APO-ENALAPRIL TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60468 |
| APO-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-11-16 | 60474 |
| APO-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60471 |
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 |